HFS
NVO

Hantz Financial Services’s Novo Nordisk NVO Stock Holding History

Hantz Financial Services’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.62M Buy
117,306
+64,004
+120% +$2.75M 0.08% 171
2026
Q1 		$1.96M Sell
53,302
-13,163
-20% -$624K 0.03% 337
2025
Q4 		$3.38M Buy
66,465
+9,039
+16% +$462K 0.05% 246
2025
Q3 		$3.19M Sell
57,426
-22,116
-28% -$1.29M 0.05% 260
2025
Q2 		$5.49M Sell
79,542
-17,393
-18% -$1.18M 0.09% 204
2025
Q1 		$6.73M Sell
96,935
-87,944
-48% -$7.26M 0.12% 180
2024
Q4 		$15.9M Buy
184,879
+2,104
+1% +$228K 0.28% 68
2024
Q3 		$21.8M Sell
182,775
-2,212
-1% -$295K 0.39% 56
2024
Q2 		$26.4M Buy
184,987
+17,609
+11% +$2.33M 0.51% 45
2024
Q1 		$21.5M Sell
167,378
-8,684
-5% -$1.03M 0.42% 55
2023
Q4 		$18.2M Buy
176,062
+70,259
+66% +$6.95M 0.4% 62
2023
Q3 		$9.62M Buy
105,803
+78,477
+287% +$6.91M 0.24% 125
2023
Q2 		$2.21M Buy
27,326
+454
+2% +$37.1K 0.06% 298
2023
Q1 		$2.14M Buy
26,872
+4,598
+21% +$326K 0.06% 291
2022
Q4 		$1.51M Buy
22,274
+3,038
+16% +$178K 0.05% 324
2022
Q3 		$958K Buy
19,236
+13,898
+260% +$745K 0.03% 360
2022
Q2 		$297K Buy
+5,338
New +$296K 0.01% 479
2021
Q4 		– Sell
-5,196
Closed -$249K – 894
2021
Q3 		$249K Buy
5,196
+14
+0.3% +$677 0.01% 468
2021
Q2 		$217K Buy
5,182
+40
+0.8% +$1.55K 0.01% 455
2021
Q1 		$173K Sell
5,142
-812
-14% -$28.9K 0.01% 443
2020
Q4 		$208K Buy
+5,954
New +$206K 0.01% 400

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Hantz Financial Services's NVO Position: Q2 2026 in Review

Hantz Financial Services increased its Novo Nordisk (NVO) stake by 120% in Q2 2026, buying an estimated $2.75M and bringing the position to 117,306 shares worth $5.62M. The position accounts for 0.08% of the portfolio, ranked #171.

Hantz Financial Services first reported a position in NVO in Q4 2020 and has held it in 21 quarters since. The position peaked at $26.4M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Hantz Financial Services held 117,306 shares of Novo Nordisk worth $5.62M as of Q2 2026.
  • Hantz Financial Services bought 64,004 Novo Nordisk shares in Q2 2026, an estimated $2.75M.
  • Novo Nordisk made up 0.08% of Hantz Financial Services's portfolio in Q2 2026, its #171 holding.
  • Hantz Financial Services first reported a position in Novo Nordisk in Q4 2020 and has held it in 21 quarters since.
  • Hantz Financial Services's Novo Nordisk position peaked at $26.4M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.